Evidence map›Paper›PMID 23563743›Full record

ArticleMicrobial ecology2013

Complex marine natural products as potential epigenetic and production regulators of antibiotics from a marine Pseudomonas aeruginosa.

Bin Wang, Amanda L Waters, James W Sims, Alexis Fullmer, Serena Ellison, Mark T Hamann

Abstract read
In one paragraph

Article in Microbial ecology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. β-Lactams from the Ocean.Marine drugs · 2023
    Review
  5. Review
  6. Two new 2-alkylquinolones, inhibitory to the fish skin ulcer pathogenBeilstein journal of organic chemistry · 2018
    Article
  7. Article
  8. Marine actinomyceteBiochemical systematics and ecology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bin WangDepartment of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.
Amanda L Waters
James W Sims
Alexis Fullmer
Serena Ellison
Mark T Hamann

Funding

Natural Product HCV Drugs from Rare Plant-Microbe InteractionsR01AT007318 · NCCIH · UNIVERSITY OF MISSISSIPPI · PI HAMANN, MARK T · 2012 to 2016
$1.6M
Biosynthetic Routes to Drug Development for AIDS Ol MtbF32AI083157 · NIAID · UNIVERSITY OF MISSISSIPPI · PI SIMS, JAMES W · 2009 to 2010
$91k
RENOVATION OF FOURTH FLOOR OF FASER HALLC06RR014503 · NCRR · UNIVERSITY OF MISSISSIPPI · PI WELLS, BARBARA G · 1999 to 1999
–
NCCIH NIH HHS R01 AT007318NCCIH NIH HHS R01AT007318NCRR NIH HHS C06 RR014503NCRR NIH HHS C06 RR-14503-01NIAID NIH HHS F32 AI083157NIAID NIH HHS F32AI083157
6 · The paper itself

Abstract

Marine microbes are capable of producing secondary metabolites for defense and competition. Factors exerting an impact on secondary metabolite production of microbial communities included bioactive natural products and co-culturing. These external influences may have practical applications such as increased yields or the generation of new metabolites from otherwise silent genes in addition to reducing or limiting the production of undesirable metabolites. In this paper, we discuss the metabolic profiles of a marine Pseudomonas aeruginosa in the presence of a number of potential chemical epigenetic regulators, adjusting carbon sources and co-culturing with other microbes to induce a competitive response. As a result of these stressors certain groups of antibiotics or antimalarial agents were increased most notably when treating P. aeruginosa with sceptrin and co-culturing with another Pseudomonas sp. An interesting cross-talking event between these two Pseudomonas species when cultured together and exposed to sceptrin was observed.

Indexed as

Anti-Bacterial AgentsBiological ProductsEpigenomicsGeologic SedimentsPseudomonas aeruginosaSeawaterAnti-Bacterial AgentsBiological Products

Identifiers

PMID23563743
PMCPMC3650628

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.